Anika Therapeutics ANIK
NASDAQ ANIK
$19.94 -0.74 (-3.55%)
At close: Sep 29, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Restructuring Costs (2013)

Updated

Anika Therapeutics (ANIK) reported Restructuring Costs of $111,178 for Q2 2013, down 18.0% from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Restructuring Costs (2013) Analysis & Trends

For FY2012, Anika Therapeutics posted Restructuring Costs of $2.54 million.

  • Restructuring Costs has a three-year compound annual growth rate of 5.7% (FY2009 to FY2012).
  • By year, Restructuring Costs came in at $2.15 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Anika Therapeutics 276.76 Mn 10.21 Mn 21.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 111,178.00
Mar 31, 2013 135,607.00
API Access

Anika Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ANIK&period=max&api_key=YOUR_API_KEY